Dr. Reshma Kewalramani is the CEO and President of Vertex Pharmaceuticals, a leading biotechnology company. She joined Vertex in 2017 as the Chief Medical Officer, before assuming the CEO role in 2020. Dr. Kewalramani has been instrumental in expanding Vertex’s portfolio, particularly in cystic fibrosis, overseeing the approval of breakthrough therapies such as TRIKAFTA/KAFTRIO​.

Dr. Kewalramani’s leadership philosophy centers on patient-centric innovation and fostering the next generation of scientists. She is passionate about diversity in STEM and serves on several boards, including the Biomedical Science Careers Program and RIZE Massachusetts​. 

Under her leadership, Vertex aims to develop transformative therapies for various diseases, enhancing patient outcomes and continuing its legacy of scientific excellence. Indiaspora is proud to have Dr. Reshma Kewalramani in our Business Leaders List for 2024.